机构地区:[1]天津市医药科学研究所,天津300020 [2]中南大学湘雅药学院,长沙410013
出 处:《中国药房》2021年第7期794-801,共8页China Pharmacy
基 金:国家自然科学基金资助项目(No.81903565);天津市自然科学基金资助项目(No.18JCQNJC13500);天津市卫生健康科技人才培育项目(No.KJ20079)。
摘 要:目的:制备一种新型的纳米多孔花形乳糖(FL)装载姜黄素(Cur)干粉吸入剂(DPI),为难溶性药物治疗慢性阻塞性肺疾病提供一种安全、高效的肺内递药方式。方法:采用溶液吸附法制备FL微粒装载Cur(Cur-FL)复合粉末。以载药量和吸附率为指标,通过单因素试验优选Cur投药浓度、Cur与FL的投药比例(m/m)和吸附时间,以确定Cur-FL复合粉末的最佳制备工艺。采用傅里叶变换红外光谱、扫描电子显微镜、差示扫描量热法等技术对以最优工艺制备的Cur-FL复合粉末的理化性质进行表征;测定其含水量并考察其空气动力学性质;通过体外模拟人工肺液环境,探讨其体外释药行为。结果:Cur-FL复合粉末的最佳制备工艺为Cur投药浓度5 mg/mL、Cur与FL的投药比例1∶4、吸附时间1 h。所得复合粉末的载药量为(23.37±0.43)%、包封率为(91.64±0.44)%、吸附率为(30.50±0.72)%。Cur-FL微粒呈花形外观;Cur被物理吸附在FL微粒孔隙内,未发生化学变化。Cur-FL复合粉末的松密度为(0.21±0.02)g/cm^(3)、振实密度为(0.33±0.01)g/cm^(3)、休止角为(24.07±0.31)°、平均粒径为(3.96±0.80)μm、空气动力学粒径为(3.33±0.99)μm、含水量为(5.63±0.24)%、排空率为(92.53±0.87)%、体外有效部位沉积率为(45.93±1.77)%;其在人工肺液中的24 h溶解度[(358.93±1.67)μg/mL]为Cur的3.28倍、48 h累积体外释放率(90.21%)为Cur的1.63倍,而Cur+FL物理混合物不能提高Cur在人工肺液中的溶解度和释放度。结论:所制Cur-FL复合粉末的体外释药性能较好,且其粉体学性质、溶解性、水分、流动性及空气动力学性能等均符合《中国药典》对DPI的要求。OBJECTIVE:To preparea novel Curcumin(Cur)dry powder inhalation(DPI)loaded by nanoporous flower-shaped lactose(FL),and to provide a safe and effective intrapulmonary drug delivery method for the therapy of chronic obstructive pulmonary disease with insoluble drugs.METHODS:FL-loaded Cur(Cur-FL)compound powder was prepared by solution adsorption method.Using drug-loading amount and adsorption rate as indicators,single-factor experiment was used to optimize Cur concentration,Cur-FL ratio(m/m)and adsorption time so as to determine the optimal preparation technology for Cur-FL compound powder.Fourier transform infrared spectroscopy,scanning electron microscope and differential scanning calorimetry were used to characterize the physical and chemical properties of Cur-FL compound powder prepared with optimal technology.The water content and aerodynamic properties were determined;in vitro drug release behavior was investigated by simulating the environment of artificial lung fluid.RESULTS:The optimal preparation technology of Cur-FL compound powder was Cur concentration of 5 mg/mL,Cur-FL ratio of 1∶4,adsorption time of 1 h.The drug-loading amount of compound powder was(23.37±0.43)%,the encapsulation rate was(91.64±0.44)%,and the adsorption rate was(30.50±0.72)%.Cur-FL particles were flower shaped;Cur was physically adsorbed in the pores of FL without chemical changes.The bulk density of Cur-FL compound was(0.21±0.02)g/cm^(3),tap density was(0.33±0.01)g/cm^(3),angle of repose was(24.07±0.31)°,average particle size was(3.96±0.80)μm,aerodynamic particle size was(3.33±0.99)μm,water content was(5.63±0.24)%,emptying rate was(92.53±0.87)%,and deposition rate of effective parts in vitro was(45.93±1.77)%.Its 24 h solubility in artificial lung fluid([358.93±1.67)μg/mL]were 3.28 times of Cur,48 h cumulative release ratesin in vitro(90.21%)were 1.63 times of Cur,but Cur+FL physical mixture could not improve the solubility and release of Cur in artificial lung fluid.CONCLUSIONS:Cur-FL compound powder has good in vitr
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...